Assessment of governance and corruption in the pharmaceutical sector : lessons learned from low and middle income countries (English)

Pharmaceuticals are a critical input for the health sector. At the same time, the drug business sustains many individual and corporate livelihoods and produces handsome returns for those involved in the trade. Good governance is critical for the sector to maximize returns for public health and minimize risks for patients from ineffective or contaminated drugs. Given the large financial volume of the market, the potential for corruption is significant...

DETAILS

Author

Diack,Aissatou;

Seiter,Andreas;

Hawkins,Loraine;

Dweik,Imad Subhi;
Document Date
2010/01/01
Document Type
Working Paper
Report Number
53074
Volume No
1
Total Volume(s)
1
Country
World,
Region
Other,
Disclosure Date
2010/07/01
Disclosure Status
Disclosed
Doc Name
Assessment of governance and corruption in the pharmaceutical sector : lessons learned from low and middle income countries
Keywords
millennium development goal

DOWNLOADS

COMPLETE REPORT

Official version of document (may contain signatures, etc)

Official PDF
TXT*
Total Downloads** : 870
Download Stats
*The text version is uncorrected OCR text and is included solely to benefit users with slow connectivity.

Citation

Diack,Aissatou; Seiter,Andreas; Hawkins,Loraine; Dweik,Imad Subhi.

Assessment of governance and corruption in the pharmaceutical sector : lessons learned from low and middle income countries (English). Health, Nutrition and Population (HNP) discussion paper Washington, DC: World Bank. http://documents.worldbank.org/curated/en/847101468159915936

Assessment of governance and corruption in the pharmaceutical sector : lessons learned from low and middle income countries (English)

DETAILS

DOWNLOADS

COMPLETE REPORT

Citation

RELATED LINKS

SUBSCRIBE TO EMAIL ALERTS